14-23424107-G-C

Variant summary

Our verdict is Pathogenic.
>+14 Pathogenic
-7
-6
-1
0
+5
+6
+9
+10
B
LB
VUS
LP
P
The variant received 21 classification points (ACMG Germline Pathogenicity v2019). PS3PM1PM2PM5PP2PP3_ModeratePP5_Very_Strong

The NM_000257.4(MYH7):c.2722C>G (p.Leu908Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a cumulative frequency of 0.00000372 (AC=6) in the gnomAD database across 1,614,104 control chromosomes (no homozygotes observed). The grpmax filtering allele frequency (95% CI) is 0.00000488. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. Variant has been reported in ClinVar as Pathogenic/Likely Pathogenic (★★★). ClinVar reports functional evidence for this variant: "SCV000692499: "In vitro assays suggest that the variant may impact myosin cross-bridge kinetics (Palmiter et al., 2000) and increase the velocity by which myosin translocated actin (Alpert NR, et al., 2005)."" and additional evidence is available in ClinVar. A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.L908M: Likely_pathogenic (ClinVar VariationId 2763277, 1 star) Other variants at the same amino acid position have been reported in ClinVar (not pathogenic): p.L908= (synonymous): Likely_benign (ClinVar VariationId 763750, 1 star) This exact variant is curated in the UniProt human variants database as Uncertain Significance.

Frequency

Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

MYH7
NM_000257.4 missense

Scores

15
5

Clinical Significance

Pathogenic reviewed by expert panel P:17

Conservation

PhyloP100: 2.98

Publications

26 publications found
Variant links:
Genes affected
MYH7 (HGNC:7577): (myosin heavy chain 7) Muscle myosin is a hexameric protein containing 2 heavy chain subunits, 2 alkali light chain subunits, and 2 regulatory light chain subunits. This gene encodes the beta (or slow) heavy chain subunit of cardiac myosin. It is expressed predominantly in normal human ventricle. It is also expressed in skeletal muscle tissues rich in slow-twitch type I muscle fibers. Changes in the relative abundance of this protein and the alpha (or fast) heavy subunit of cardiac myosin correlate with the contractile velocity of cardiac muscle. Its expression is also altered during thyroid hormone depletion and hemodynamic overloading. Mutations in this gene are associated with familial hypertrophic cardiomyopathy, myosin storage myopathy, dilated cardiomyopathy, and Laing distal myopathy. [provided by RefSeq, May 2022]
MYH7 Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy 1S
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, ClinGen, Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • hypertrophic cardiomyopathy 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • MYH7-related skeletal myopathy
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet, ClinGen
  • myopathy, myosin storage, autosomal recessive
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • myopathy, myosin storage, autosomal dominant
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • Ebstein anomaly
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • familial isolated dilated cardiomyopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hyaline body myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • left ventricular noncompaction
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • arrhythmogenic right ventricular cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen, G2P
  • congenital heart disease
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_000257.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

Classification according to ACMG Germline Pathogenicity v2019

Classification was made for transcript:

Our verdict: Pathogenic. The variant received 21 points.

PS3Functional studies show damaging effect
Well-established functional study supports damaging effect (PS3); SCV000692499: "In vitro assays suggest that the variant may impact myosin cross-bridge kinetics (Palmiter et al., 2000) and increase the velocity by which myosin translocated actin (Alpert NR, et al., 2005)."; SCV000917841: The rate of translocation of acting filaments as measured by in-vitro motility assays was 35% of wild-type levels (Cuda_1993). Subsequently, a gain of function effect was observed as an increase in actin filament velocity in the in-vitro motility assay (Palmiter_2000) and an increase in actin sliding velocity (Alpert_2005).; SCV000208505: Published functional studies demonstrated L908V increases the velocity of actin filament movement in the in vitro motility assays performed using cardiac or skeletal muscle tissue from L908V heterozygous individuals (Palmiter et al., 2000; Alpert et al., 2005).; SCV000280334: "There is functional data available: Cuda et al. (1993, 1997) took skeletal muscle biopsies from HCM patients with this variant, and showed that the mutant cardiac myosin is also present in skeletal muscle and has abnormal function in an in vitro assay in which actin filaments are translocated by myosin bound to a coverslip surface." Cuda et al. (1993, 1997); SCV000319946: "In vitro motility assays showed an increase in actin filament velocities and gain of function (Palmiter KA et al. J Muscle Res Cell Motil. 2000;21(7):609-20; Alpert NR et al. Am J Physiol Heart Circ Physiol. 2005;288(3):H1097-102)."; SCV000059471: studies have shown that this variant may impact protein function (Cuda 1993, Alpert 2005).; SCV000546238: Experimental studies have shown that this missense change affects MYH7 function (PMID: 8483915, 9172070, 11227787, 15528230).; SCV004844781: An in vitro motility assay has shown that the mutant protein exhibits enhanced mechanical performance at the single molecule level (PMID: 11227787).; SCV001341816: An in vitro motility assay has shown that the mutant protein exhibits enhanced mechanical performance at the single molecule level (PMID: 11227787).
PM1Mutational hot spot or critical domain
UniProt domain with ≥4 pathogenic missense and OR ≥ 5 vs. background — hotspot (PM1); In-domain: 106 pathogenic, 0 benign rare missense variants (OR vs. background: 1065.0).; ±8 AA neighbourhood: 20 pathogenic, 0 benign (OR vs. background: 205.0).
PM2Absent/extremely low in population databases
Very rare in gnomAD for AD/XL gene (popmax AF < threshold/10) — PM2; GnomAD popmax AF = 0.00000488 — very rare for AD+AR gene (threshold 0.0001) — PM2 moderate.
PM5Novel missense at known pathogenic residue
Different pathogenic missense at same AA residue in ClinVar (PM5); ClinVar contains a germline Pathogenic/Likely Pathogenic entry at the same amino acid position with a different amino acid change: p.L908M: Likely_pathogenic (ClinVar VariationId 2763277, 1 star); Other variants at the same amino acid residue (not pathogenic): p.L908= (synonymous): Likely_benign (ClinVar VariationId 763750, 1 star)
PP2Missense in gene with low missense rate
Missense in gene constrained for missense variation where missense is common disease mechanism (PP2); Missense in a gene constrained for missense variation (gnomAD Z-score: 6.806). ClinVar shows strong pathogenic missense enrichment: 622 P/LP and 50 B/LB missense entries (ratio 12.4×).
PP3Computational evidence supports damaging effect
Germline meta computational scorer (REVEL/MetaRNN/BayesDel) predicts damaging effect — moderate evidence (PP3); Splicing verdict: not pathogenic.; Germline computational verdict: pathogenic (Moderate).
PP5Reputable source reports pathogenic
ClinVar ≥3 stars pathogenic — very strong (PP5); ClinVar submissions overwhelmingly pathogenic (≥10 total, ≥80% P/LP, <10% B/LB) — strong (PP5, count-based); ClinVar germline classification: Pathogenic/Likely Pathogenic, 3 star(s). ClinVar submissions strongly and reliably favor pathogenicity (17/17 total P/LP).

Variant Effect in Transcripts

Automated classification analysis was done for transcript: NM_000257.4. You can select a different transcript below to see updated classification assignments.

RefSeq Transcripts

MYH7 NM_000257.4
MANE Select
HGVSc / HGVSpc.2722C>Gp.Leu908Val
Exon rankExon 23 of 40
missense
Prot: NP_000248.2UniProt: P12883
MYH7 NM_001407004.1
HGVSc / HGVSpc.2722C>Gp.Leu908Val
Exon rankExon 22 of 39
missense
Prot: NP_001393933.1UniProt: P12883

Ensembl Transcripts

MYH7 ENST00000355349.4
TSL:1MANE Select
HGVSc / HGVSpc.2722C>Gp.Leu908Val
Exon rankExon 23 of 40
missense
Prot: ENSP00000347507.3UniProt: P12883
MYH7 ENST00000858540.1
HGVSc / HGVSpc.2722C>Gp.Leu908Val
Exon rankExon 23 of 40
missense
Prot: ENSP00000528599.1UniProt: A0ACI8PLM0
MYH7 ENST00000965955.1
HGVSc / HGVSpc.2722C>Gp.Leu908Val
Exon rankExon 23 of 40
missense
Prot: ENSP00000636014.1UniProt: A0ACI8PLM0

Frequencies

Allele frequencies (AF), counts (AC/AN), homozygotes and coverage

Common (AF > 0.05 / Hom > 5)
Rare (AF ≤ 0.0001 / Hom ≤ 1)
Global population databases 5 sources
GnomAD3 genomes
AF: 0.0000131
AC:2
Hom:0
AN:152222
Cov:32
GnomAD4 exome
AF: 0.00000274
AC:4
Hom:0
AN:1461882
Cov:34
GnomAD4 genome
AF: 0.0000131
AC:2
Hom:0
AN:152222
Cov:32
TOPMed (Bravo)
AF: 0.0000113
AC:3
Hom:0
AN:264690
ALFA (dbGaP/dbSNP Allele Frequency Aggregator)
AF: 0.0000523
AC:2
Hom:0
AN:38206
Showing 5 sources

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Hypertrophic cardiomyopathy (4)
4
-
-
not provided (4)
3
-
-
Hypertrophic cardiomyopathy 1 (3)
2
-
-
Cardiomyopathy (2)
2
-
-
Cardiovascular phenotype (2)
2
-
-
Primary familial hypertrophic cardiomyopathy (2)

Computational Scores

AlphaGenome AVI
Pathogenic23
AlphaMissense
Uncertain0.42
BayesDel_addAF
Pathogenic0.47D
BayesDel_noAF
Pathogenic0.43
CADD
Uncertain24
CardioboostCm
Pathogenic1.0
DANN
Uncertain1.0
DEOGEN2
Pathogenic0.86D
Eigen
Pathogenic0.91
Eigen_PC
Pathogenic0.83
FATHMM_MKL
Uncertain0.96D
FuncVEP CTI
Pathogenic0.93
GPN-Star LLR
N/A-9.0
GPN-Star score
N/A9.0
LIST_S2
Uncertain0.91D
M_CAP
Pathogenic0.94D
MetaRNN
Pathogenic0.89D
MetaSVM
Pathogenic1.0D
Mutation Taster
N/A2/98disease causing (ClinVar)
MutationAssessor
Pathogenic4.5H
PhyloP100
Benign3.0
popEVE
Benign-3.4
PrimateAI
Pathogenic0.81D
PROVEAN
Uncertain-2.4N
REVEL
Pathogenic0.78
Sift
Pathogenic0.0D
Sift4G
Pathogenic0.0010D
Varity_R
N/A0.54
VESM-3B
Benign-10
Showing 29 of 29 scores

Splicing Scores

Pangolin (max)
Benign0.020
SpliceAI score (max)
Benign0.0
Details are displayed if max score is > 0.2
Showing 2 of 2 scores

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

MaveDB functional evidence

MaveDB is a public repository of laboratory assays that test the effect of thousands of variants at once — treat this as supporting research data and interpret it with great caution; it is not a clinical classification.

No MaveDB functional evidence found for this variant.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.